Global pioneer Prof B S Bhoop wins prestigious IPA Eminent Pharmacist Award 2025: Our Bureau, Chennai Friday, November 28, 2025, 12:25 Hrs [IST] Professor Bhupinder Singh Bhoop, a ...
Cothera Bioscience’s zotiraciclib for treatment of recurrent high-grade glioma receives US FDA fast track designation: San Mateo, California Friday, November 28, 2025, 12:00 Hrs ...
Sun Pharmaceutical’s updated label for Unloxcyt receives US FDA approval: Our Bureau, Mumbai Friday, November 28, 2025, 11:40 Hrs [IST] Sun Pharmaceutical Industries Limited ann ...
WHO releases policy brief on priority setting in TB programme planning: Geneva Friday, November 28, 2025, 11:00 Hrs [IST] The World Health Organization (WHO) has released a new po ...
TempraMed Technologies inks exclusive distribution agreement with Guri to market TempraMed's products across Israel: Vancouver, British Columbia Friday, November 28, 2025, 10:00 H ...
US FDA accepts and grants priority review status to BeOne Medicines’ sonrotoclax to treat relapsed or refractory mantle cell lymphoma: San Carlos, California Friday, November 28 ...
High level Ethiopian delegation visits Telangana to study drug regulatory excellence: Peethaambaran Kunnathoor, Chennai ...
IPC to train small-scale pharma & medtech firms in strengthening PV & MV reporting for patient safety: Shardul Nautiyal, Mumbai Friday, November 28, 2025, 08:00 Hrs [IST] The Indi ...
India must fast-track talent training pipelines to power next wave of cell & gene therapy: Dr Hingorani: Nandita Vijayasimha, Bengaluru Friday, November 28, 2025, 08:00 Hrs [IST] ...
Credit guarantee scheme to help maintain cash flow and financial stability for pharma exporters: Experts: Shardul Nautiyal, Mumbai Friday, November 28, 2025, 08:00 Hrs [IST] The C ...
DCC agrees to add one more strength of emergency contraceptive levonorgestrel into Schedule K: Gireesh Babu, New Delhi Friday, November 28, 2025, 08:00 Hrs [IST] The Drugs Consult ...
WHO approves OS Therapies’ daznelimgene lisbac for non-proprietary name for product candidate OST-HER2: New York Thursday, November 27, 2025, 18:00 Hrs [IST] OS Therapies Inc, t ...